A REVIEW REPORT ON LYRICA (PREGABALIN) AS ANTIEPILEPTIC AGENT 

Journal Title: Journal of Biological and Scientific Opinion - Year 2013, Vol 1, Issue 4

Abstract

Epilepsy is a chronic disorder of the central nerve system (CNS). It affects 5-10 per 1000 of the general population. There are different types of epilepsies. For the identification of different kinds of epilepsies different test and physical examination will perform by the doctors, further to treatment of this disease the treatment involves surgery and medication. For medication of this disease many kinds of antiepileptic drugs are available which are divided into many chemical classes. Lyrica pregabalin is the new antiepileptic drug which is introduced as an antiepileptic agent in 30th December 2004 by the FDA. It is a structural derivative of the inhibitory neurotransmitter gamma amino butyric acid (GABA). Dizziness and drowsiness are the most common (>10 % patients) adverse effect of pregabalin. A hypersensitivity to pregabalin or other component of the product may develop, resulting in an unfavorable interaction with the body. Pregabalin cross the blood–brain barrier in mice, rats, and monkeys. Approximately 98 % of the radioactivity recovered in the urine was unchanged pregabalin. N-methyl is the major metabolite of pregabalin. It has been assigned to pregnancy category ‘C’ by the FDA. Pregabalin is also used off-label for the treatment of chronic pain, neuropathic pain, preoperative pain, and migraine. The maximum dosing regimen is 600 mg/day. 

Authors and Affiliations

Sumit Kumar, Swatantra Singh

Keywords

Related Articles

SCOPE OF AYURVEDIC DRUGS AND LEECH THERAPY IN MANAGEMENT OF VARICOSE VEIN OF LOWER LIMB  

Varicose veins are appearing commonly among older people, in women, obese patient as overweight (which increases the excessive pressure in the veins of the lower limbs). The Modern medicine has a few invasive techniques,...

AN OVERVIEW ON TECHNIQUES IMPLEMENTED FOR DISSOLUTION ENHANCEMENT OF ACECLOFENAC 

Aceclofenac is aceclofenacum (O–(2, 6-dichloroaniline) phenyl] acetate glycolic acid ester, 2–(2, 6-dichloraniline) phenyl acetoxy acetic acid. Aceclofenac is a Non- Steroidal Anti Inflammatory drug. It is used in the ma...

UTILITY OF THE CONCEPT OF GARBHOTPADAKA SAMAGRI (ESSENTIAL FACTORS FOR CONCEPTION) IN THE PRESENT ERA  

Fertilization is essential for propagation of species and their evolution. It is the process of union of male and female gametes resulting in the formation of a zygote. Thereafter implantation and growth of the fetus tak...

EFFECT OF HYDROALCOHOLIC EXTRACTS OF PARKINSONIA ACULEATA L. AND ANANUS COMOSUS L. ON OXOTREMORINE INDUCED PARKINSONISM IN WISTAR ALBINO RATS 

Parkinson’s disease is progressive neurodegenerative disease that occurs due to several causative factors although dopamine deficiency is prime characteristic of the disease. Environmental toxin, genetic abnormalities, d...

AN AYURVEDA APPROACH IN THE MANAGEMENT OF VERNAL KERATO CONJUNCTIVITIS: A CASE STUDY  

Vernal kerato conjunctivitis(VKC) or spring catarrh is a recurrent, bilateral and self-limiting inflammation of conjunctiva, having a periodic seasonal incidence. It is an allergic disorder in Which IgE mediated mechanis...

Download PDF file
  • EP ID EP136320
  • DOI 10.7897/2321–6328.01426
  • Views 74
  • Downloads 0

How To Cite

Sumit Kumar, Swatantra Singh (2013). A REVIEW REPORT ON LYRICA (PREGABALIN) AS ANTIEPILEPTIC AGENT . Journal of Biological and Scientific Opinion, 1(4), 403-411. https://europub.co.uk/articles/-A-136320